Oxford Biomedica (OTC:OXBDF)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Tuesday.

TRADEMARK VIOLATION NOTICE: “Oxford Biomedica’s (OXBDF) Buy Rating Reaffirmed at HC Wainwright” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/11/02/oxford-biomedicas-oxbdf-buy-rating-reaffirmed-at-hc-wainwright.html.

Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.